| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.084 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.087 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.092 | 0.09 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.059 | 0.2 |